Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs enoxaparin for thromboprophylaxis after bariatric surgery in obese patients
IRCT20220530055031N7Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in obesity and venous thromboembolism (VTE) comparing Apixaban arm with Enoxaparin arm (2 arms). Started Dec 2024; status: completed.
02
Drugs
apixabanenoxaparin
03
Conditions
obesityvenous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20220530055031N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220530055031N7.